-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
CymaBay Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2017 to Q4 2023.
- CymaBay Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $596K.
- CymaBay Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was -$3.69M, a 71.4% increase year-over-year.
- CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$3.69M, a 71.4% increase from 2022.
- CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$12.9M, a 434% decline from 2021.
- CymaBay Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.42M, a 250% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)